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Abstract
The β2-integrin lymphocyte function-associated antigen 1 (LFA-1) plays an important role in
the migration, adhesion and intercellular communication of dendritic cells (DCs). During the
differentiation of human DCs from monocyte precursors, LFA-1 ligand binding capacity is
completely lost, even though its expression levels were remained constant. Yet LFA-1-
mediated adhesive capacity on DCs can be regained by exposing DCs to the chemokine
CCL21, suggesting a high degree of regulation of LFA-1 activity during the course of DC dif-
ferentiation. The molecular mechanisms underlying this regulation of LFA-1 function in
DCs, however, remain elusive. To get more insight we attempted to identify specific LFA-1
binding partners that may play a role in regulating LFA-1 activity in DCs. We used highly
sensitive label free quantitative mass-spectrometry to identify proteins co-immunoprecipi-
tated (co-IP) with LFA-1 from ex vivo generated DCs. Among the potential binding partners
we identified not only established components of integrin signalling pathways and cytoskel-
etal proteins, but also several novel LFA-1 binding partners including CD13, galectin-3,
thrombospondin-1 and CD44. Further comparison to the LFA-1 interaction partners in
monocytes indicated that DC differentiation was accompanied by an overall increase in
LFA-1 associated proteins, in particular cytoskeletal, signalling and plasma membrane
(PM) proteins. The here presented LFA-1 interactome composed of 78 proteins thus repre-
sents a valuable resource of potential regulators of LFA-1 function during the DC lifecycle.
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Introduction
Integrins form a family of heterodimeric transmembrane receptors that regulate cell–adhesion
and cell-extracellular matrix interactions. Lymphocyte function-associated antigen 1 (LFA-1,
αLβ2) is a leukocyte specific integrin that mediates firm arrest of leukocytes on the endothe-
lium during migration and establishes cell-cell contacts such as the immunological synapse
between DCs and T cells [1]. At the molecular level, transient modifications of adhesion are
accomplished by conformational changes of LFA-1 from a bent down inactive to an upright
active conformation with an open headpiece, leading to low- and high-affinity for its major
ligand ICAM-1 respectively [2]. These conformational changes are induced by binding of the
cytoskeletal protein talin as the terminal step in a process termed “inside-out” signalling where
intracellular signalling events lead to changes in integrin activity and alter cell adhesion [3]. In
the context of cell-adhesion, integrins in turn deliver “outside-in” signals upon ligand binding
that control cell proliferation, survival, gene induction, differentiation and cell motility. To
achieve this, integrins recruit molecular complexes consisting of numerous cytoskeletal and
signalling molecules [4].
Several studies have addressed the interaction partners of integrins in ligand-induced adhe-
sion complexes [5–9] and in different modes of cell adhesion [10]. So far, over 190 proteins
from different cellular systems have been described to constitute the focal adhesion network
[7,11], which led to the identification of key regulatory proteins acting during the adhesion to
different ligands [6]. However, little is currently known about the steady-state organization of
integrins within the plasma membrane (PM) and the molecules involved in regulating their
activity prior to ligand encounter. In an attempt to describe a leukocyte-specific “pro-adhesive”
integrin network, Laudanna and colleagues summarized 64 proteins that are involved in integ-
rin regulation prior to ligand binding, which had been derived from different experimental sys-
tems and cell types [12]. How exactly the molecular assembly and interaction partners prior to
ligand encounter vary between integrins, cell types and differentiation states, and how molecu-
lar pre-assemblies relate to the spatiotemporal regulation of integrin function, remains elusive.
We have previously shown that during in vitro differentiation of primary human monocytes
towards immature monocyte-derived DCs (imDCs), LFA-1 remains expressed at similar levels,
but loses its upright/functional form. In addition, DC LFA-1 is no longer organized in defined
PM nanoclusters of ~100nm in size but rather has a random distribution [13,14]. As recently
shown by our group, DC LFA-1 however could be reactivated by the chemokine CCL21 [15]
indicating that LFA-1 adhesive properties are subject to a high level of regulation during DC
differentiation and exposure to external stimuli. In this respect, others have shown that pre-
organized signalling platforms may facilitate ligand encounter and/ or promote a rapid trans-
mission and response to intracellular signalling events [16–18], which could play a role in the
regulation of LFA-1 in DCs. To identify proteins associated with LFA-1 on in vitro cultured
DCs that may constitute such signalling platforms we here used selective immuno-precipita-
tion (IP) of LFA-1 followed by highly sensitive label free quantitative mass-spectrometry (MS)
analysis. Our results describe a unique signature of LFA-1 interacting proteins in DCs, contain-
ing established and potentially novel LFA-1 binding partners. Only part of this DC derived
LFA-1 interactome was also connected to LFA-1 in monocytes. These proteins may have
important implications for the adhesive properties of LFA-1 in DCs and in other cell types.
Based on these identified interaction partners we reconstructed a DC-specific LFA-1 Protein-
Protein Interaction (PPI) network involving 78 proteins that represents a great resource for
future studies on the molecular regulation of LFA-1 function.
Reconstruction of the LFA-1 Interactome in Dendritic Cells
PLOS ONE | DOI:10.1371/journal.pone.0149637 February 18, 2016 2 / 23
(269019) and KWO award KUN2009-4402 of the
Dutch Cancer Society (www.kwf.nl).
Competing Interests: The authors have declared
that no competing interests exist.
Materials and Methods
Cells
Monocytes were isolated from buffy coats (Sanquin) obtained from healthy volunteers after
written informed consent and according to institutional guidelines, verified by the local institu-
tional review board (Commissie mensgebonden onderzoek (CMO)). Peripheral blood mono-
nuclear cells were purified from buffy coats using Ficoll density centrifugation. Monocytes
were isolated by plate adherence. DCs were obtained by culturing adherent monocytes in the
presence of interleukin-4 (300U/ml) and granulocyte macrophage colony-stimulating factor
(450U/ml) (both from Strathmann, Hamburg Germany). MoDCs were cultured for 6 days to
obtain imDCs.
Immunoprecipitation
Monocytes and imDCs were thoroughly washed with PBS and subsequently lysed directly in
the flask with lysis buffer (20mM Tris pH 8, 150mMNaCl, 1mM CaCl2, 1mMMgCl2) contain-
ing either 1% Brij 97 (Brij buffer) or 1% Nonidet P-40 + 0.5% sodium deoxycholate + 0.1%
SDS (RIPA buffer), in the presence of protease (Complete, Roche) and phosphatase inhibitors
(Phosphostop Roche). After 15 min lysis on ice, cell lysates were cleared by centrifugation at
14000g for 15 min. First, cell lysates were precleared with bovine serum albumin-coated pro-
tein G sepharose beads (GE Healthcare), followed by empty protein G sepharose beads in the
presence of 1/1000 volume heat inactivated goat serum, and finally by preclearing with mouse
IgG1 coated (2μg) protein G sepharose beads. Each step was performed at 4°C for 1 hour. Pro-
teins were then immunoprecipitated by adding protein G sepharose beads coated with 5μg of
specific anti-CD11a antibody (SPV-L7 [19]) or 5μg unspecific mouse IgG1 isotype antibody to
400μl lysate. After 2 h incubation under constant agitation at 4°C, beads were washed five
times in Brij 97 or RIPA lysis buffer. The immunoprecipitates were separated by SDS-PAGE
under reducing conditions. Proteins in the gel were visualized with colloidal coomassie staining
(Invitrogen).
Western blotting
Proteins were separated by SDS-PAGE and transferred to PVDF membranes (Millipore, Bed-
ford, MA). Subsequently, proteins were detected by immunoblotting. After labelling, Western
blots were scanned by the Odyssey imager (LI-COR Biosciences).
Microscopy
For co-capping experiments, day 6 monocyte-derived imDCs were double-stained at 4°C with
5μg/ml anti–LFA-1 mAb (clone NKI-L15, mIgG2a or clone TS2/4, mIgG1) and 5μg/ml mAbs
against Galectin-3 (clone M3/38, ratIgG2a), CD44 (clone G44-26, mIgG2b), CD71 (clone b3/
25, mIgG1) or CD13 (clone WM15, mIgG1). Isotype-specific controls were always included.
Secondary staining was performed with Alexa 488–conjugated goat anti–mouse IgG2a or
IgG2b and Alexa 647–conjugated goat anti–mouse IgG1. Patching was induced by incubation
at 15°C for 1 h, followed by fixation with 1% paraformaldehyde. Cells were mounted onto
poly-l-lysine–coated glass coverslips. Fixed cells were imaged on an FV1000 confocal laser
scanning microscope (Olympus, Tokyo, Japan) equipped with argon (488 nm) 559- and
635-nm diode lasers using a PlanApochromatic 60×/1.35 numerical aperture (NA) oil immer-
sion objective.
Signals were collected sequentially to avoid bleed through. The Pearson correlation coeffi-
cient was calculated by applying the Image J (http://rsb.info.nih.gov/ij/,) plug-in JACoP [20]
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and reflects the amount of LFA-1 co-localizing with Galectin-3, CD44, CD13 or CD71 sepa-
rately for each cell.
Sample preparation for LC-MS/MS experiments
Protein samples were loaded on a 8% SDS PAGE gel, followed by a short electrophoresis period
of 5 minutes, stained with colloidal Coommassie blue and divided into a single gel slice per
sample. Gel slices were treated with dithiothreitol (DTT) and iodoacetamide and digested by
trypsin [21]. Digested samples were acidified to a final concentration of 0.1% trifluoroacetic
acid and purified by self-made and extremely economical stop-and-go-extraction tips
(STAGE) tips [22].
Liquid chromatography tandemmass spectrometry
Peptide sequencing experiments were performed by LC-MS/MS using a nano HPLC Agilent
1100 LC system connected to a 7-Tesla linear ion trap ion cyclotron resonance Fourier trans-
form (LTQ-FT Ultra) mass spectrometer (Thermo Fisher, Bremen, Germany) and measured as
described previously [21]. Peptides were separated on 15 cm 100 μm ID PicoTip columns
(New Objective, Woburn, USA) packed with 3 μm Reprosil C18 beads (Dr. Maisch GmbH,
Ammerbuch, Germany) using a 120 min gradient from 12% buffer B to 40% buffer B (buffer B
contains 80% acetonitrile in 0.5% acetic acid) with a flow-rate of 300 nl/min The mass spec-
trometer was operated with a spray voltage of 2.2 kV, and data was acquired in a data-depen-
dent mode with full-scan MS spectra of intact peptides (m/z 350–1500) with an automated
gain control accumulation target value of 1,000,0000 ions in the Fourier transform ion cyclo-
tron resonance cell with a resolution of 50,000. The four most abundant ions were sequentially
isolated and fragmented in the linear ion trap by applying collisionally induced dissociation
using an accumulation target value of 10,000, a capillary temperature of 100°C, and a normal-
ized collision energy of 27%. A dynamic exclusion of ions previously sequenced within 180 s
was applied. All unassigned charge states and singly charges ions were excluded from sequenc-
ing. A minimum of 200 counts was required for MS2 selection. Maximum injection times were
set at 500 ms and 400 ms respectively for FT MS and IT MS/MS measurements.
Protein identification and quantification
Raw spectrum files were processed for identification by the Andromeda search engine [23] and
quantification according to the iBAQmethod [24] with MaxQuant version1.2.0.18 [25].
(http://maxquant.org/). Peak lists were generated using the default setting that extracted the
top 6 MSMS peaks per 100 Da. Proteins were identified by searching peak lists with Androm-
eda against the human International Protein Index (IPI) database version 3.68 (ftp://ftp.ebi.ac.
uk/pub/databases/IPI/) supplemented with frequently observed contaminants using the target
decoy approach. Search parameters for protein identification specified a mass tolerance of
7ppm for the parental peptide and 0.5 Da for fragmentation spectra and a trypsin specificity
allowing up to 3 miscleaved sites. Carbamidomethylation of cysteines was specified as a fixed
modification, and oxidation of methionine, deamidation of glutamine and asparagine, and
acetylation of the protein N-terminus were set as variable modifications. The required minimal
peptide length was set at 6 amino acids. Peptide validation by establishing false discovery rates
(FDR) was performed by MaxQuant as described [25]. We accepted peptides (charge state>1,
nr variable modifications<4) with peptide FDR of 1% and proteins with a protein PEP<0.002
and protein FDR of 1%.
Proteins were quantified by label free quantification using the intensity- based absolute
quantification (iBAQ) [24]. Protein intensities were calculated by MaxQuant as the normalised
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sum of all identified peptide intensities s. Protein intensities were determined in duplicate mea-
surements, then normalised by median iBAQ value and finally averaged. The criteria for pro-
tein selection were the following: for stringent IP conditions we selected proteins that were at
least 2.5 fold enriched over the isotype control (based on the normalized IBAQ value), or that
were specifically detected in the LFA-1 IP by at least 3 unique peptides. In mild IP conditions
we included proteins that were 2.5 fold enriched over the isotype control, or, if LFA-1 IP spe-
cific, detected with at least 2 peptides.
Protein protein interaction network analysis
The STRING (STRING v9.1) database (http://string-db.org/) [26] was used to retrieve high
confidence (0.6), direct protein interactions (based on experimental evidence) within the lists
of putative LFA-1 binding partners in monocytes and DCs, separately. The final PPI network
layout was redrawn by the authors, based on the graphical PPI network generated in STRING.
The Ingenuity pathways analysis (IPA)
The Ingenuity pathways analysis (IPA) software (Ingenuity Systems, Redwood City, CA) is a
bioinformatics tool that puts experimental data in relation to published research by identifying
relationships, mechanisms, functions, and pathways of relevance. The LFA-1 binding candi-
dates in monocytes and DC were analysed for the top 5 most enriched IPA pathways against a
background of all human proteins by right tailed Fisher Exact Tests in a core analysis calculat-
ing the likelihood that this is due to random chance.
Antibodies
The following primary antibodies were used for Western blotting and confocal analysis: mouse
anti-human LFA-1 (clone NKI-L15 and TS2/4, hybridoma), rabbit anti-human LFA-1
(EP1285Y, Abcam), rat-anti Galectin-3 (clone M3/38, Biolegend), mouse anti-human CD13
(clone WM15, biolegend), mouse anti-human CD44 (clone G44-26, BD biosciences), mouse
anti-human Talin-1 (clone 8d4, Sigma), mouse anti- Actin (clone AC-40, Sigma), rabbit anti-
human thrombospondin-1 (Abcam), mouse anti-human CD71 (clone b3/25, hybridoma).
IRDye conjugated secondary antibodies for Western blotting were obtained from LI-COR Bio-
sciences, and Alexa-647 conjugated secondary antibodies for flow cytometry and confocal anal-
ysis were from Invitrogen. For LFA-1 immunoprecipitation studies, an antibody directed
specifically against the αL chain was used (clone SPV-L7).
Results
Isolation of LFA-1 associated proteins in DCs
To investigate which proteins are associated with LFA-1 in DCs prior to ligand binding, we
performed IPs of LFA-1 from primary human in vitro derived DCs and analyzed precipitated
proteins by quantitative nano liquid chromatography tandem mass spectrometry (LC-MS/MS)
(Fig 1A). Western blotting (WB) and FACS analysis confirmed our previous finding that the
LFA-1 protein levels remained steady during differentiation of monocytes towards DC (Fig
1B), while the cell surface expression of the extended/functional conformation of LFA-1 was
lost in DCs [13] (Fig 1B). LFA-1 complexes were efficiently purified from DCs by beads coated
with a specific antibody directed at the αL chain of LFA-1 (Fig 1C). To retrieve only proteins
strongly interacting with LFA-1 and to obtain a high confidence of the interaction, cell lysis
and IP were performed in the presence of a stringent detergent on DCs obtained from 3 differ-
ent donors. As expected based on our WB results, colloidal Coomassie staining showed a clear
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presence of protein at the expected molecular weight of the integrin αL- and β-chain. In addi-
tion, the Coomassie stained gel already revealed several other proteins specifically present in
the LFA-1 precipitate of DCs that were not precipitated with an isotype-matched control anti-
body (Fig 1D). Both IP samples were subsequently subjected to LC-MS/MS and proteins were
identified and quantified by MaxQuant applying the label free iBAQmethod [24]. Both the
larger number of peptides derived from αL and β2 identified by mass spectrometry as well as
the approximately 10 fold higher iBAQ values for both subunits, confirmed enrichment of
LFA-1 in the LFA-1 targeting IP with respect the isotype control-IP, as expected from the
Western blot data (Table 1; Fig 1).
Fig 1. Enrichment and identification of LFA-1 complexes. (A) Experimental flow chart for enrichment and
identification of LFA-1 complexes in imDCs. Adherent imDCs from 3 healthy donors were lysed, followed by
enrichment of LFA-1 by IP and separation by SDS-PAGE. The protein content was visualized by colloidal
coomassie labeling, excised in one piece and subjected to MS analysis and protein identification. (B) Top:
Immunolabeling of LFA-1 in cell lysates of equal amounts of monocytes (day0) and imDCs on day 3,5 and 6
of DC differentiation. Loading control: actin. Bottom: Expression levels of total (TS2/4) and active/extended
(NKI-L16) cell surface LFA-1 assessed by flow cytometry. (Isotype control, dotted line; extended LFA-1, grey;
total LFA-1, black). (C) Immunolabeling of immunoprecipitated LFA-1 from the post nuclear supernatant
(PNS) of day 6 imDCs. (D) Colloidal coomassie staining of SDS-PAGE gels from immunoprecipiated LFA-1
in DCs. LFA-1 was enriched using mAb (clone SPV-L7) directed against αL. mIgG1 coated beads were
included as control IP. LFA-1 subunits and potential interaction partners are indicated by arrow heads.
Protein bands specifically identified in the LFA-1 IP are indicated by asterisk.
doi:10.1371/journal.pone.0149637.g001
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Table 1. Protein binding partners identified in stringent IP conditions in DCs.
Protein
AcNR
HGNC
symbol
Protein Name (IPA) normalized
IBAQ control
IP
normalized
IBAQ LFA-1
IP
max
peptides
control
max
peptides
LFA-1 IP
fold change
(LFA-1 IP/
Control IP)
1 IPI00221224 ANPEP alanyl (membrane) aminopeptidase nd 18.25 0 15 LFA-1 IP
speciﬁc
2 IPI00221226 ANXA6 annexin A6 nd 4.30 0 11 LFA-1 IP
speciﬁc
3 IPI00333541 FLNA ﬁlamin A, alpha nd 0.99 0 11 LFA-1 IP
speciﬁc
4 IPI00867509 CORO1C coronin, actin binding protein, 1C nd 9.81 0 11 LFA-1 IP
speciﬁc
5 IPI00294739 SAMHD1 SAM domain and HD domain 1 nd 4.55 0 9 LFA-1 IP
speciﬁc
6 IPI00024067 CLTC clathrin, heavy chain (Hc) nd 0.63 0 8 LFA-1 IP
speciﬁc
7 IPI00171903 HNRNPM heterogeneous nuclear
ribonucleoprotein M
nd 2.01 0 8 LFA-1 IP
speciﬁc
8 IPI00793199 ANXA4 annexin A4 nd 6.08 0 7 LFA-1 IP
speciﬁc
9 IPI00477313 HNRNPC heterogeneous nuclear
ribonucleoprotein C (C1/C2)
nd 7.75 0 5 LFA-1 IP
speciﬁc
10 IPI00299719 TCIRG1 T-cell, immune regulator 1,
ATPase, H+ transporting,
lysosomal V0 subunit A3
nd 0.90 0 4 LFA-1 IP
speciﬁc
11 IPI00304171 H2AFY H2A histone family, member Y nd 2.04 0 4 LFA-1 IP
speciﬁc
12 IPI00873622 WDR1 WD repeat domain 1 nd 0.93 0 4 LFA-1 IP
speciﬁc
13 IPI00909703 ANXA11 annexin A11 nd 7.09 0 4 LFA-1 IP
speciﬁc
14 IPI00008530 RPLP0 ribosomal protein, large, P0 nd 1.08 0 3 LFA-1 IP
speciﬁc
15 IPI00019912 HSD17B4 hydroxysteroid (17-beta)
dehydrogenase 4
nd 0.52 0 3 LFA-1 IP
speciﬁc
16 IPI00027438 FLOT1 ﬂotillin 1 nd 0.43 0 3 LFA-1 IP
speciﬁc
17 IPI00220834 XRCC5 X-ray repair complementing
defective repair in Chinese hamster
cells 5 (double-strand-break
rejoining)
nd 0.71 0 3 LFA-1 IP
speciﬁc
18 IPI00295857 COPA coatomer protein complex, subunit
alpha
nd 0.34 0 3 LFA-1 IP
speciﬁc
19 IPI00298994 TLN1 talin 1 nd 0.06 0 3 LFA-1 IP
speciﬁc
20 IPI00305064 CD44 CD44 molecule (Indian blood
group)
nd 1.46 0 3 LFA-1 IP
speciﬁc
21 IPI00465431 LGALS3 lectin, galactoside-binding, soluble,
3
nd 13.10 0 3 LFA-1 IP
speciﬁc
22 IPI00855785 FN1 ﬁbronectin 1 nd 0.34 0 3 LFA-1 IP
speciﬁc
23 IPI00902560 VDAC2 voltage-dependent anion channel 2 nd 1.29 0 3 LFA-1 IP
speciﬁc
24 IPI00939163 HSPH1 heat shock 105kDa/110kDa protein
1
nd 0.49 0 3 LFA-1 IP
speciﬁc
25 IPI00418169 ANXA2 annexin A2 4.46 993.57 8 22 223.02
(Continued)
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Table 1. (Continued)
Protein
AcNR
HGNC
symbol
Protein Name (IPA) normalized
IBAQ control
IP
normalized
IBAQ LFA-1
IP
max
peptides
control
max
peptides
LFA-1 IP
fold change
(LFA-1 IP/
Control IP)
26 IPI00010477 LGALS9 lectin, galactoside-binding, soluble,
9
0.56 34.79 1 3 61.98
27 IPI00021812 AHNAK AHNAK nucleoprotein 0.12 7.44 1 71 61.70
28 IPI00216691 PFN1 proﬁlin 1 0.40 14.58 1 5 36.02
29 IPI00453473 PPIA peptidylprolyl isomerase A
(cyclophilin A)
2.51 84.31 2 3 33.63
30 IPI00646240 HIST2H2BF histone cluster 2, H2bf 0.62 18.80 1 4 30.44
31 IPI00294578 TGM2 transglutaminase 2 0.68 14.51 5 11 21.23
32 IPI00005159 ACTR2 ARP2 actin-related protein 2
homolog (yeast)
2.83 59.03 4 4 20.85
33 IPI00169383 PGK1 phosphoglycerate kinase 1 0.08 1.42 2 5 17.37
34 IPI00011644 PTPRE protein tyrosine phosphatase,
receptor type, E
0.08 1.24 1 6 15.58
35 IPI00029741 ITGB5 integrin, beta 5 1.09 16.59 1 1 15.25
36 IPI00291792 ITGB2 integrin, beta 2 4.62 62.62 10 20 13.54
37 IPI00013163 MNDA myeloid cell nuclear differentiation
antigen
0.07 0.80 2 3 11.20
38 IPI00003918 RPL4 ribosomal protein L4 0.25 2.76 1 3 10.92
39 IPI00016342 RAB7A RAB7A, member RAS oncogene
family
0.27 2.90 1 3 10.75
40 IPI00926935 GNAI2 guanine nucleotide binding protein
(G protein), alpha inhibiting activity
polypeptide 2
0.31 3.24 1 4 10.37
41 IPI00941721 PTPN6 protein tyrosine phosphatase, non-
receptor type 6
0.07 0.67 1 3 9.83
42 IPI00025380 ITGAL integrin, alpha L (antigen CD11A
(p180), lymphocyte function-
associated antigen 1; alpha
polypeptide)
6.34 60.23 20 28 9.50
43 IPI00291764 SLC25A6 solute carrier family 25
(mitochondrial carrier; adenine
nucleotide translocator), member 6
1.51 13.85 1 3 9.20
44 IPI00555744 RPL14 ribosomal protein L14 0.23 1.88 1 1 8.26
45 IPI00180675 TUBA1A tubulin, alpha 1a 0.22 1.78 1 2 8.12
46 IPI00883857 HNRNPU heterogeneous nuclear
ribonucleoprotein U (scaffold
attachment factor A)
0.21 1.67 1 5 8.00
47 IPI00215914 ARF1 ADP-ribosylation factor 1 1.63 12.69 1 4 7.77
48 IPI00010471 LCP1 lymphocyte cytosolic protein 1 (L-
plastin)
1.07 8.12 7 13 7.58
49 IPI00005969 CAPZA1 capping protein (actin ﬁlament)
muscle Z-line, alpha 1
0.35 2.50 1 2 7.24
50 IPI00009342 IQGAP1 IQ motif containing GTPase
activating protein 1
0.06 0.46 2 5 7.20
51 IPI00028091 ACTR3 ARP3 actin-related protein 3
homolog (yeast)
1.37 9.05 5 6 6.61
52 IPI00550069 RNH1 ribonuclease/angiogenin inhibitor 1 0.28 1.86 1 4 6.54
53 IPI00925520 PFKL phosphofructokinase, liver 0.07 0.44 1 2 5.91
54 IPI00010415 ACOT7 acyl-CoA thioesterase 7 0.10 0.55 1 3 5.40
55 IPI00376798 RPL11 ribosomal protein L11 0.66 3.40 1 1 5.13
(Continued)
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Table 1. (Continued)
Protein
AcNR
HGNC
symbol
Protein Name (IPA) normalized
IBAQ control
IP
normalized
IBAQ LFA-1
IP
max
peptides
control
max
peptides
LFA-1 IP
fold change
(LFA-1 IP/
Control IP)
56 IPI00215719 RPL18 ribosomal protein L18 0.72 3.65 1 1 5.06
57 IPI00414676 HSP90AB1 heat shock protein 90kDa alpha
(cytosolic), class B member 1
1.96 9.85 5 9 5.04
58 IPI00179330 RPS27A ribosomal protein S27a 3.20 15.66 2 2 4.89
59 IPI00930688 TUBA1B tubulin, alpha 1b 4.66 21.68 5 10 4.66
60 IPI00013508 ACTN1 actinin, alpha 1 2.58 11.80 16 24 4.57
61 IPI00396378 HNRNPA2B1 heterogeneous nuclear
ribonucleoprotein A2/B1
0.69 2.71 2 3 3.94
62 IPI00219910 BLVRB Biliverdin Reductase B (Flavin
Reductase (NADPH))
0.54 2.11 1 1 3.92
63 IPI00871870 ARPC3 actin related protein 2/3 complex,
subunit 3, 21kDa
1.14 4.41 1 1 3.87
64 IPI00641829 DDX39B DEAD (Asp-Glu-Ala-Asp)
box polypeptide 39B
0.84 3.06 3 3 3.65
65 IPI00645452 TUBB tubulin, beta class I 7.69 26.75 12 12 3.48
66 IPI00456887 HNRNPUL2 heterogeneous nuclear
ribonucleoprotein U-like 2
0.15 0.50 1 1 3.43
67 IPI00792352 LIPA lipase A, lysosomal acid,
cholesterol esterase
0.87 2.99 1 2 3.41
68 IPI00011253 RPS3 ribosomal protein S3 0.45 1.50 2 4 3.36
69 IPI00303476 ATP5B ATP synthase, H+ transporting,
mitochondrial F1 complex, beta
polypeptide
1.08 3.62 4 6 3.35
70 IPI00027230 HSP90B1 heat shock protein 90kDa beta
(Grp94), member 1
0.33 1.07 1 6 3.26
71 IPI00016610 PCBP1 poly(rC) binding protein 1 1.17 3.78 3 3 3.22
72 IPI00604523 MYL12A myosin, light chain 12A, regulatory,
non-sarcomeric
33.54 106.22 7 7 3.17
73 IPI00397834 FERMT3 fermitin family member 3 0.99 2.98 4 8 3.00
74 IPI00008964 RAB1B RAB1B, member RAS oncogene
family
0.12 0.35 1 1 2.98
75 IPI00005161 ARPC2 actin related protein 2/3 complex,
subunit 2, 34kDa
2.20 6.46 5 6 2.93
76 IPI00019884 ACTN2 actinin, alpha 2 0.07 0.21 1 1 2.91
77 IPI00221221 ALOX15 arachidonate 15-lipoxygenase 1.13 3.27 7 9 2.90
78 IPI00295741 CTSB cathepsin B 0.26 0.73 1 1 2.82
79 IPI00294158 BLVRA biliverdin reductase A 0.25 0.70 1 1 2.76
80 IPI00027107 TUFM Tu translation elongation factor,
mitochondrial
0.18 0.48 1 1 2.67
81 IPI00926581 MYH14 myosin, heavy chain 14, non-
muscle
23.43 61.93 3 2 2.64
82 IPI00215918 ARF4 ADP-ribosylation factor 4 0.29 0.75 1 1 2.59
83 IPI00025491 EIF4A1 eukaryotic translation initiation
factor 4A1
1.37 3.48 2 4 2.53
The criteria for protein selection were the following: proteins were at least 2.5 fold enriched over the isotype-type matched control IP (based on the
normalized IBAQ value), or were speciﬁcally detected in the LFA-1 IP with a minimum of 3 unique peptides. Proteins were mapped to HGNC and
International Protein Index (IPI) identiﬁers. nd = not detected.
doi:10.1371/journal.pone.0149637.t001
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Identification of LFA-1 associated proteins in DCs
To derive candidate binding partners of LFA-1 we took into account only proteins that were
either detected specifically in the LFA-1 IP with a minimum of 3 peptides and were absent in
the control IP, or that were at least 2.5 fold enriched in the LFA-1 IP (based on normalized
IBAQ value) over the control IP. Applying those criteria, a total of 94 entries were scored as
potential interaction partners of LFA-1 in DCs (Table 1). These entries corresponded to the
specific international protein index (IPI) and could be mapped to 83 HUGO Gene Nomencla-
ture Committee (HGNC) annotated proteins. Among the interaction partners we found the
established integrin binding partners, kindlin-3 (FERMT3) and talin-1 (TLN1), as well as
many other proteins that are known to be involved in integrin signaling and cell adhesion and
that may thus play a role in the regulation of LFA-1 function (Table 1).
When comparing these interactions partners to components of published ligand-induced
integrin-complexes [6,7,11], we found an overlap of 14 proteins with the adhesome and of 24
proteins with a proteomic analysis of β1integrin-associated complexes [6]. In total, 32 of the
here identified proteins (38.5%) overlapped with published integrin interactomes (Fig 2). This
overlap is quite high, considering that the highlighted studies focused on other integrins and,
importantly, were performed in the presence of ligand. In contrast, we studied proteins inter-
acting with LFA-1 at steady-state LFA-1 prior to ligand binding. This suggests that the overlap-
ping proteins may represent more general and unconditional integrin interaction partners. The
eight proteins shared among all data sets were ADP-ribosylation factor 1 (ARF1), capping pro-
teins (actin filament) muscle Z-line alpha1 (CAPZA1), Clathrin heavy chain 1 (CLTC), coro-
nin1C (CORO1C), filamin A (FLNA), flotillin 1 (FLOT1), Ras GTPase-activating-like protein
IQGAP1 (IQGAP1) and talin-1 (Fig 2). Uniquely shared with the two datasets were mainly
cytoskeletal proteins and, in case of the adhesome, also some ribosomal proteins which most
likely represent a remaining pollution of these highly abundant proteins inevitably present in
unbiased proteome analysis.
To further highlight the enrichment of proteins relevant for integrin function in our dataset
and to understand which molecular pathways the identified LFA-1 interaction partners are
assigned to, we performed ingenuity pathway analysis (IPA). First, gene IDs of LFA-1 binding
candidates were mapped to the Ingenuity’s knowledge database containing predefined
Fig 2. Comparison of LFA-1 binding partners in DCs with published ligand-induced integrin
complexes. Venn diagrams of proteins identified in this study (green), proteins summarized in the focal
adhesion adhesome by Geiger et al [11] (blue) and proteins identified in experimental ligand induced integrin
complexes by Humphries et al [6] (yellow). Numbers of identified proteins, as well as gene symbols of
commonly identified proteins by Geiger et al, Humphries et al and this study are indicated.
doi:10.1371/journal.pone.0149637.g002
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canonical pathways. The LFA-1 interaction partners in DCs were significantly overrepresented
in the canonical pathway “integrin signaling” (p = 3.17E-12), confirming selective precipitation
of proteins involved in integrin function (Table 2). Also overrepresented were the pathways
“Remodeling of Epithelial Adherens Junctions” (p = 5.52E-15), “Actin Cytoskeleton Signaling”
(p = 7.85E-12) and “Epithelial Adherens Junction Signaling” (p = 3.01E-11), (Table 2), which
also clearly relate to integrin activity. We then evaluated the coverage of these signaling path-
ways by defining the fraction of proteins in the data to the total size of the pathway. The cover-
age ranged from 6–16%, with the highest coverage in the pathway “Remodeling of Epithelial
Adherens Junctions” (Table 2).
Validation of LFA-1 binding partners in DCs
Next, we sought to validate some of the identified candidate proteins by Western Blotting
(WB). As the formation of LFA-1 nanoclusters and LFA-1 activity is lost during DC differenti-
ation [13,15], we were specifically interested in proteins that interact with LFA-1 in the PM
rather than those that may interact with LFA-1 in intracellular organelles. Of the proteins that
passed our enrichment criteria we selected the potential LFA-1 interaction partners galectin-3
(LGALS3), thrombospondin-1 (THBS1), CD13 (ANPEP) and CD44, as well as the established
binding partners kindlin-3 (FERMT3) and talin-1 (TLN1) for further study. WB analysis was
in agreement with the results from the MS, demonstrating co-IP of thrombospondin-1, talin-1,
CD13 and galectin-3 with LFA-1 in DCs (Fig 3A).
Proximity of LFA-1 to CD13, CD44 and galectin-3 at the PM
Not all antibodies available to us allowed confirmation of interaction with LFA-1 by Co-IP and
WB. As an alternative approach to validate the relation of these proteins to LFA-1, we also
examined the proximity of LFA-1 with the PM receptors and PM- associated proteins CD13,
CD44 and galectin-3 by mAb-induced capping and confocal microscopy (Fig 3B). When co-
capping was induced, LFA-1 strongly colocalized with galectin-3 in the PM with a Pearson´s
coefficient of 0.85 (Fig 3B and 3C). CD13 and CD44 localization after capping also correlated
significantly with LFA-1 (Pearson´s coefficients 0.8 and 0.72 respectively) in contrast to the
non-LFA-1 associated protein CD71 (0.52). Thus, our data confirm that CD13, galectin-3 and
CD44 reside in proximity to LFA-1 in the PM, however further experiments are required to
elucidate their role in LFA-1 function and whether they interact directly or indirectly with
LFA-1.
In-silico reconstruction of the LFA-1 protein-protein interaction network
in DCs
Having confirmed the validity of our proteomics data by WB and microscopy, we next aimed
to reconstruct the steady-state LFA-1 interactome in primary human DCs from the list of 83
Table 2. Ingenuity Pathway Analysis: Top Canonical Pathways in DCs (stringent IP conditions).
Name Fisher Exact Test p value Pathway coverage
1 Remodeling of Epithelial Adherens Junctions 5,52E-15 16.2%
2 Integrin Signaling 3,17E-12 6.4%
3 Actin Cytoskeleton Signaling 7,85E-12 6%
4 Epithelial Adherens Junction Signaling 3,02E-11 7.5%
5 Paxillin Signaling 2,69E-07 6.9%
doi:10.1371/journal.pone.0149637.t002
Reconstruction of the LFA-1 Interactome in Dendritic Cells
PLOS ONE | DOI:10.1371/journal.pone.0149637 February 18, 2016 11 / 23
proteins (including α and β chain of LFA-1) identified as strong LFA-1 interactors (Table 1).
To construct a PPI network we next interrogated the database of functional protein interac-
tions (STRING v9.05) for experimentally proven protein-protein interactions. For better visu-
alization of proteins involved in integrin function we excluded 19 proteins corresponding to
ribosomal and histone complexes, which likely represent a pollution of these highly abundant
proteins. The remaining 64 proteins were uploaded to STRING and a network of 19 directly
interacting proteins could be formed (Fig 4; confidence score 0.6), potentially representing the
core network of strong LFA-1 interactors in DCs. This network contained 31 connections,
resulting in an average of 0.48 connections per protein in our list of 64 LFA-1 binding partners
(Table 1).
As a source of additional nodes to further construct the LFA-1 network we complemented
our high confident IP performed under stringent lysis conditions with IPs of DC LFA-1 per-
formed in the presence of a mild detergent. The IP performed in mild conditions resulted in
Fig 3. Validation of MS results byWB and proximity study by confocal microscopy for selected proteins. (A) Protein complexes of LFA-1,
thrombospondin-1, talin-1, CD13 (top) and galectin-3 (bottom) in imDCs (day6) were co-immunoprecipitated with LFA-1. LFA-1 was enriched using mAb
(clone SPV-L7) directed against αL (CD11a). mIgG1 coated beads were included as control IP. PNS: post nuclear supernatant. Samples were analysed in
non-reducing conditions. (B) Confocal microscopy analysis of co-capping of LFA-1 and galectin-3, CD44 and CD71 on imDCs (day6). Receptor co-capping
and staining were performed as described inMaterial and Methods. Antibodies against LFA-1 (clones: NKI-L15 and TS2/4) and CD71 are positive and
negative markers for co-localization, respectively. Results are representatives of multiple cells per condition (n>10.) in two independent experiments. (C) To
quantify the degree of co-localization between LFA-1 and binding candidates, Pearson´s coefficient was calculated. The values can vary between 0 and 1
(1 = 100% colocalization). P-values were compared to co-capping of LFA-1 with CD71 by two-tailed t-test, *** <0.001. Co-capping and staining were
performed as described in Materials and Methods.
doi:10.1371/journal.pone.0149637.g003
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the same IP efficacy as stringent IP condition, as confirmed by WB (data not shown) and pep-
tide count (S2 Table). Our aim was to use the less stringently LFA-1 associated proteins as a
“LFA-1-interactome-enriched” fishing pool to extract indirect higher order binding partners
for the proteins retrieved under stringent conditions. For maximal sensitivity in detecting
potential LFA1 interactors, we applied slightly less stringent criteria for unique proteins now
demanding 2 unique peptides in the specific IP or at least 2.5 fold iBAQ enrichment over con-
trol IP in one of the performed experiments. Applying these enrichment criteria for the mild IP
condition, we now identified 171(IPI) proteins (mapping to 161 HGNC symbols) as LFA-1
binding candidates (S1 Table), of which 24 proteins were also identified in stringent IP condi-
tions (Fig 5A).
To construct a PPI network we next fused the data sets derived from mild and stringent IP
conditions (again after removal of ribosmal and histone complex proteins) and interrogated
Fig 4. Protein-protein interaction of directly interacting LFA-1 binding candidates derived from DCs in
stringent lysis conditions. A network was generated by uploading the protein names to the database of
functional protein interactions (STRING v9.05) and retrieving experimentally proven direct protein-protein
interactions. The resulting network was drawn by the authors. Based on our MS data, we could retrieve a high
confidence network (score 0.6) of 19 directly interacting nodes (Fig 5), enriched in 31 connections. * indicates
an interaction that was not present in the STRING database (version 9.1) with experimental support, but this
node and interactions were added by the authors based on the current literature [27].
doi:10.1371/journal.pone.0149637.g004
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Fig 5. Protein-protein interaction network of directly interacting LFA-1 binding candidates derived from DCs. (A) Comparison of immunoprecipitated
LFA-1 from day 6 imDCs in mild and stringent lysis conditions. Venn diagrams of proteins identified in DCs in stringent (red) and mild (blue) IP conditions.
Numbers of identified proteins, as well as common proteins (yellow) are indicated. (B) A network of LFA-1 (heterodimer formed by an αL (ITGAL) and β2
(ITGB2) chain) binding partners was generated by fusing the data sets derived frommild and stringent IP conditions in DCs, uploading the protein names to
the database of functional protein interactions (STRING v9.05) and retrieving experimental proven direct protein-protein interactions. (ribosomal and histone
complexes were removed for better visualization of proteins involved in integrin function). The resulting network was redrawn by the authors. Based on our
MS data, we could construct a high confidence network (score 0.6) containing 78 nodes and 154 connections. Blue nodes represent proteins identified in
mild lysis conditions, and red nodes represent proteins identified in stringent lysis conditions. Green nodes represent proteins identified both in mild and
stringent IP condition. * indicates an interaction that was not present in the STRING database (version 9.1) with experimental support, but this node and
interactions were added by the authors based on the current literature [27].
doi:10.1371/journal.pone.0149637.g005
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the database of functional protein interactions (STRING v9.05). We then constructed a highly
confident PPI network (confidence score 0.6) (Fig 5B) composed of 78 proteins and 154 inter-
actions. The network links cytoskeletal, signaling and scaffolding proteins to both secreted and
PM associated proteins, including the known interaction partners Rap1a (RAP1A), kindlin-3,
talin-1 and vinculin (VCL), as well as the novel LFA-1 interactors galectin-3 and thrombospon-
din-1 confirmed in this study (Fig 5B). Of all proteins in the network, vinculin represents the
best connected node with 13 connections, followed by talin-1 with 12 connections and actin
(Acta1) and growth factor receptor-bound protein 2 (GRB2) with 10 connections, suggesting a
fundamental role of these proteins in LFA-1 function in DCs (Fig 5B). Interestingly, based on
STRING, only 6 proteins directly interacted with the α or β chain of LFA-1, while the majority
of protein interactions are of secondary-tertiary, or higher degree nature, suggesting that large
protein complexes are associated with LFA-1 in the steady-state in DCs
Addition of the proteins derived uniquely by mild IP conditions to the initial LFA-1 net-
work resulted in a larger network with 78 proteins directly connected by 154 interactions (Fig
5B) and this exercise thus doubled the average connection of the identified LFA-1 binding part-
ners from 0.48 (for stringent IP condition only) to 0.96 when the combined list was uploaded
(159 proteins, after removal of ribosomal and histone complexes). The obtained network con-
tained 3.5 fold more connections than could be expected based on an equally sized set of ran-
dom proteins predicted by STRING. Taken together, this indicates that we have constructed a
network of proteins that have a high potential to act together to regulate LFA-1 function in
DCs (Fig 5B).
LFA-1 interactome in monocytes
Having reconstructed a LFA-1 PPI network in primary DCs from our MS data, we were next
wondering how specific this network was for DCs and whether the changes with respect to
LFA-1 function, activation state and cell surface organization in DCs were reflected in the rep-
ertoire of LFA-1 binding partners. To this end, we used a comparable IP strategy on primary
human monocytes, which we use as precursors to generate DCs. The efficacy of the LFA-1 IP
from monocytes was similar to the LFA-1 IPs performed in DCs (S2 Table). As potential inter-
action partners for LFA-1 in monocytes we identified in total (i.e. both mild and stringent con-
ditions) 117 unique proteins mapped to HGNC symbol (S2 Table), slightly less than in DCs, of
which 45 were shared between monocytes and DCs, including the known integrin interaction
partner Rap1A and the scaffolding protein IQGAP1 (Fig 6A). Next, we interrogated STRING
to build a PPI network based on the LFA-1 binding candidates identified in monocytes. This
high confidence LFA- PPI network (score of 0.6) only contained 19 proteins forming a coher-
ent network by 24 connections, resulting in an average connection of 0.23 per protein detected
in mild and stringent IP conditions in monocytes (104 proteins after removal of ribosomal and
histone complexes) (Fig 6B). Overall, we identified more LFA-1 interactors in DCs, suggesting
that the underlying LFA-1 PPI network may be more complex in DCs.
Together, the here described established as well as potentially novel interaction partners of
LFA-1 may map the way to a better understanding of the regulatory mechanisms acting on
LFA-1 in DCs and monocytes as depicted in the cartoon (Fig 7). The interaction partners iden-
tified may function to steer LFA-1 intracellular trafficking, plasma membrane organization,
activation and signalling and provide a valuable resource for future LFA-1 research.
Discussion
We have previously shown that LFA-1 undergoes dramatic changes in function and cell surface
organization during in-vitro differentiation of moDCs, changing from a discrete nanoclusters
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organisation and extended conformation to randomly distributed inactive LFA-1 [13,15]. LFA-
1 adhesive behavior and motility on DCs however can be rapidly changed by the chemokine
CCL21 [15,28]. The differential regulation of LFA-1 on these cell types may reflect the different
circumstances in which LFA-1 has to act in each case. To aid monocyte extravasation into tis-
sues, pro-adhesive LFA-1 nanoclusters form high-affinity bonds to endothelial-presented
ICAM-1 which are stabilized by the high shear stress in the blood stream [29]. On DCs, LFA-1
likely plays a role during trans-lymphatic migration to the lymph nodes, where low shear stress
values prevail and a chemotactic gradient of CCL21 is present [30]. The demands of these dif-
ferent environments require distinct regulatory mechanisms to allow optimal LFA-1 function
in each case. Here we present the first effort to identify proteins specifically associated with
LFA-1 in each cell type, to get more insight into the molecules that may regulate LFA-1
function.
Together a wealth of small scale biochemical studies have so far identified more than 40 pro-
teins that directly interact with either the α or β chain of LFA-1 from different cell types
[27,31,32]. Large scale efforts to characterize the proteomes of integrin containing adhesion
complexes, including focal adhesions, invadopodia and podosomes however showed that
ligand-induced adhesion structure complexes may consist of up to 200 different proteins con-
stituting several layers of interaction [5–9], and we estimate that this number only represents
the tip of the iceberg [11]. In the present study we set out to characterize the broad LFA-1 adhe-
some prior to ligand binding by selective IP of the αL chain of LFA-1 coupled to highly
Fig 6. Comparison of total LFA-1 binding partners (derived frommild and stringent lysis conditions) in monocytes and DCs. (A) Venn diagrams of
proteins identified in monocytes (blue) and DCs (yellow). Numbers of identified proteins, as well as common proteins are indicated. (B) PPI network of directly
interacting LFA-1 (heterodimer formed by and αL (ITGAL) and β2 (ITGB2) chain) binding partners derived frommonocytes in stringent lysis and mild lysis
conditions. A network was generated by uploading the protein names to the database of functional protein interactions (STRING v9.05) and retrieving
experimental proven direct protein-protein interactions. The resulting network was drawn by the authors. Based on our MS data, we could retrieve 3 high
confidence networks (score 0.6), with a maximum of 19 directly interconnected nodes. Blue nodes represent proteins identified in mild lysis conditions, and
red nodes represent proteins identified in stringent lysis conditions.
doi:10.1371/journal.pone.0149637.g006
Reconstruction of the LFA-1 Interactome in Dendritic Cells
PLOS ONE | DOI:10.1371/journal.pone.0149637 February 18, 2016 16 / 23
sensitive MS analysis. We identified a set of proteins associated to LFA-1 in human monocyte-
derived DCs suggesting a pre-organization of LFA-1 in molecular platforms even in the
absence of ligand binding. The choice of lysis buffer greatly influenced the number of proteins
identified in DCs in our study. As expected, we identified more binding partners in mild lysis
conditions. According to our protein-protein interaction analysis, of the identified binding
partners only 6 proteins directly interacted with the α or β chain of LFA-1 and only 20 proteins
formed a coherent higher degree (e.g. secondary, tertiary) network in stringent lysis conditions,
potentially representing a core network of strong LFA-1 binding partners in DCs. Potential
binding partners derived by mild IP condition greatly enhanced the network of LFA-1 binding
partners in number and interconnectivity, suggesting that the pre-organized molecular plat-
forms associated with LFA-1 in DCs may largely be sustained by proteins only indirectly
Fig 7. Model for the Spatio-Functional Regulation of LFA-1 in monocytes and DCs. Schematic representation of LFA-1 binding partners (described by
gene symbols) in monocytes and DCs, selected from the full lists of enriched proteins identified in these cell types in this study (Table 1, S1 and S2 Tables).
The authors selected the binding candidates according to their established or potentially novel role in integrin function and cell adhesion, based on the
current literature. Candidates were grouped into categories according to their potential role and/ or cellular localization. In monocytes, in the absence of
ligand, LFA-1 (heterodimer formed by an αL (ITGAL) and β2 (ITGB2) chain) is functionally active and forms nanoclusters consisting of extended or inactive
(bent) LFA-1 molecules in the PM (A). During differentiation of monocytes towards DCs (B) LFA-1 activity is lost (all molecules are in the bent conformation)
and LFA-1 shows a random PM distribution. LFA-1 binding partners identified in both monocytes and DCs are highlighted in green.
doi:10.1371/journal.pone.0149637.g007
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associated to LFA-1. Nonetheless, by their close proximity to LFA-1, these proteins may be
very important for LFA-1 function in DCs.
Our MS data reveals that both on DCs and on monocytic precursors LFA-1 is associated
with a set of signaling and cytoskeletal proteins known to act downstream of adhesion recep-
tors in leukocytes, such as Rap1A [33], Rac2 [34], GNAi2 [35], IQGAP1 [36], actin [37], tubu-
lin [38] and thus suggesting a fundamental role of these proteins for LFA-1 function regardless
of the cell type. In addition we have identified a distinct set of LFA-1 interacting proteins only
in DCs. These proteins may facilitate the instantaneous activation and immobilization of LFA-
1 in response to CCL21 [15,28] as well as an altered organization of LFA-1 on the PM [13]
The most proximal signaling event leading to integrin activation is the binding of the cyto-
solic actin-interacting proteins kindlin-3 and talin-1, causing the separation of the integrin
cytosplasmic tails and TM region, leading to integrin extension [39,40]; therefore these pro-
teins are classically thought to interact only with active (extended) integrins. Strikingly, we
identified the interaction of both of these proteins with LFA-1 in DCs, where LFA-1 is mostly
inactive (which was confirmed by flow cytometry). In line with our finding, it was recently
reported that talin-1 colocalized with LFA-1 in DCs prior to ligand binding and that CCL21
did not increase this interaction. Ligand binding that further stabilized chemokine-induced
LFA-1 activation however did induce an increase of talin binding [28]. Others have also
reported interaction of full-length talin with inactive integrins in neutrophils [41]. Our data is
in line with the finding that talin-1 does not exclusively interact with active integrins and sug-
gests a more complex role of talin-1 and potentially kindlin-3 in LFA-1 regulation. Unexpect-
edly we could not detect talin-1 and kindlin-1 in our MS data for monocytes that have a large
amount of active LFA-1 on their surface. Possibly, in monocytes ligand binding is a prerequi-
site for the binding of talin-1 and kindlin-3 to LFA-1.
Interestingly, we specifically found the following proteins associated with integrin signalling
in the LFA-1 pull-down fraction in DCs: Protein tyrosine phosphatase, receptor type C
(PTPRE, CD148), type E (PTPRC, CD45) and 14-3-3 (YWHAZ). CD148 and CD45 regulate
membrane-associated non-receptor Src family kinases (SFK), which can directly interact with
the integrin cytoplasmic tail and regulate integrin affinity and outside-in signaling [42,43]. 14-
3-3 proteins are dimers, and the 14-3-3 αβ and δz isoforms were previously shown to associate
with the cytoplasmic tail of the β chain of LFA-1 and to regulate LFA-1–mediated cell adhesion
and spreading [44]. We also identified Spa-1 (SIPL-1), a Rap GTPase-activating protein
reported as negative regulator of cell adhesion, which could thus play a role in the inactivation
of LFA-1 during differentiation into DCs [45].
Furthermore we found a more abundant presence of proteins in the DC IP that may link
LFA-1 to the cytoskeleton and regulate actin dynamics, including components of the Arp2/3
complex, F-actin capping proteins, VASP, cofilin, coronin, WDR1 and vinculin. Vinculin
interacts directly with actin and talin through binding sites in the talin rod. Moreover, vinculin,
WDR1, cofilin and coronin appear to regulate actin turnover via Arp2/3 [46,47]. The specific
association of these cytoskeletal proteins with LFA-1 in DCs suggests a higher connectivity of
LFA-1 to the cytoskeleton, possibly facilitating efficient DC migration [48]. In this respect, we
have previously shown that LFA-1 mobility within the PM of monocytes is an important requi-
site for reinforcing binding to ICAM-1 [49]. An increased association of LFA-1 with the cyto-
skeleton in DCs could prevent mobile LFA-1 from outgrowing ligand-induced adhesion sites,
thereby hampering LFA-1-mediated adhesion, as observed during DC differentiation [13,15].
CD13/Aminopeptidase N (ANPEP) is highly expressed in both monocytes and DCs (data
not shown), yet only precipitated together with LFA-1 in DCs. We could confirm its close
proximity to LFA-1 on the DC surface and thus this protein likely represents a novel LFA-1
interaction partner. The association of integrins with metalloproteases has been shown to play
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a role in degrading ECM and to modulate receptor activity [50]. CD13 is a metallo-exopepti-
dase with demonstrated involvement in leukocyte activation and migration, by triggering cal-
cium influx, cytoskeletal rearrangements and integrin activation [51]. Its selective association
with LFA-1 in DC thus makes it an interesting candidate for further investigation.
We also identified several proteins of the galectin family including galectin-1–3 and -9 as
potential LFA-1 interaction partners. Galectins are carbohydrate binding proteins associated to
many cellular processes including signaling, migration, endocytosis and cell surface organiza-
tion via their scaffolding properties [52]. Of these galectins, galectin-3 was only detected in the
DCs IP and therefore of specific interest. We validated its association with LFA-1 using both
WB and microscopy demonstrating for the first time its connection with LFA-1. Galectin-3
uniquely forms pentamers allowing it to form glycan lattices and has been shown previously to
bind and regulate the α3β1 integrin, facilitating lamellipodia formation by activating Rac1 sig-
naling in epithelial cells [53]. Intriguingly, galectin-3 was recently also demonstrated to regu-
late a novel clathrin-independent, glycosphingolipid dependent endocytic route taken by N-
glycosylated cargo including the β1 integrins and CD44 [54]. Based on these data, it is tempting
to speculate that the specific interaction of galectin-3 with LFA-1 in DCs could point towards a
selective usage of this endocytic route in DCs. The co-precipitation of CD44 with LFA-1 and
the proximal distribution of these molecules on the DC PM could reflect their shared usage of
this route. In agreement with such a differential regulation of endocytosis in DCs and mono-
cytes we found LFA-1 in monocytes to co-precipitate with the clathrin-adaptor subunit
AP2M1 that is part of the AP-2 complex regulating clathrin mediated endocytosis from the
PM [55]. Alternatively (or concomitantly) the scaffolding properties of galectin-3 (and possibly
other galectins) could play a role in the altered membrane organization of LFA-1 on DCs with
respect to monocytes.
Overall, the DC-LFA-1PPI network constructed from our identified interaction partners
shows a high level of connectivity, increasing the likelihood that some of these interactions also
occur in vivo. However, we should be aware that our reconstruction of the DC-LFA-1 interac-
tome likely is not complete and therefore the network is only an approximation of the reality.
The complexity of our samples will have favored the detection of largest, most abundant, most
hydrophilic proteins resistant to cell lysis. Although our samples contained many established
interaction partners of LFA-1 and we could already validate the proximity of LFA-1 to the
newly identified interaction partners CD13, galectin-3 and CD44, further biochemical and
functional analysis will be needed to validate the remaining potential LFA-1 binding partners.
Nonetheless, the here presented set of possible LFA-1 interaction partners provides a valuable
resource in the search for mechanistic insight into the regulation of LFA-1 function in DCs
and monocytes.
Taken together, our results strongly support the notion that in DCs at steady-state LFA-1
resides in the vicinity of a great number of signalling, cytoskeletal and PM proteins that are
involved in inside-out and outside-in signalling, PM organisation as well as intracellular
trafficking. Such a preorganization can greatly facilitates rapid modulation of LFA-1 func-
tion in DCs, as observed upon exposure to CCL21, to quickly adapt to the requirements of
the dynamically changing DC environment. Further (MS) experiments that lie beyond the
scope of the current manuscript are needed to answer the intriguing question whether
CCL21 stimulation modifies the LFA-1 interactome or mostly acts by changing the activa-
tion state of proteins already present in pre-existing molecular platforms associated with
LFA-1 in DCs.
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